- Case Discussion: Overview of the Current Treatment Landscape for mCSPC and Implications for Nursing Practice
- Case Discussion: Overview of the Current Treatment Landscape for mCRPC and Nursing Considerations
- Advances and Future Directions for Patients With Metastatic Prostate Cancer
Date / Time
Kathleen Burns, MSN, RN, AGACNP-BC, OCN®
GU Medical Oncology
City of Hope National Medical Center
Brenda Martone, MSN, ANP-BC, AOCNP
Department of GU Oncology
The goal of this activity is to improve oncology nurses’ ability to educate and optimally care for patients with prostate cancer.
This program is intended for oncology nurses and other HCPs who care for patients with prostate cancer.
Upon completion of this activity, participants should be able to:
- Making care safer by reducing harm caused in the delivery of care
- Promoting the most effective prevention and treatment practices for the leading causes of mortality
- Promoting effective communication and coordination of care
- Ensuring that each person and family is engaged as partners in their care
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Nursing Continuing Education
Designation of Credit
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.